Table 2.
HCC development | Overall | Steatosis < 5% | Steatosis ≥ 5% | |
---|---|---|---|---|
Overall | ||||
1-year | Rate (%) | 0 | 0 | 0 |
Sample size | 310 | 243 | 67 | |
3-year | Rate (%) | 1.8 | 1.9 | 1.6 |
Sample size | 238 | 184 | 54 | |
5-year | Rate (%) | 3.2 | 1.9 | 8.2 |
Sample size | 164 | 136 | 28 | |
Ishak F0–4 | ||||
1-year | Rate (%) | 0 | 0 | 0 |
Sample size | 248 | 198 | 50 | |
3-year | Rate (%) | 0.9 | 1.1 | 0 |
Sample size | 191 | 151 | 40 | |
5-year | Rate (%) | 2.1 | 1.1 | 6.0 |
Sample size | 141 | 120 | 21 | |
Ishak F5/6 | ||||
1-year | Rate (%) | 0 | 0 | 0 |
Sample size | 62 | 45 | 17 | |
3-year | Rate (%) | 5.6 | 5.3 | 5.9 |
Sample size | 47 | 33 | 14 | |
5-year | Rate (%) | 8.0 | 5.3 | 13.7 |
Sample size | 23 | 16 | 7 |
HCC, hepatocellular carcinoma.